BR9610283A - Polimorfos da pró-droga 6-n-(l-ala-l-ala)-trovafloxacina - Google Patents

Polimorfos da pró-droga 6-n-(l-ala-l-ala)-trovafloxacina

Info

Publication number
BR9610283A
BR9610283A BR9610283A BR9610283A BR9610283A BR 9610283 A BR9610283 A BR 9610283A BR 9610283 A BR9610283 A BR 9610283A BR 9610283 A BR9610283 A BR 9610283A BR 9610283 A BR9610283 A BR 9610283A
Authority
BR
Brazil
Prior art keywords
ala
trovafloxacin
pro
drug polymorphs
polymorphs
Prior art date
Application number
BR9610283A
Other languages
English (en)
Inventor
Timothy Norris
James J Mcgarry
Douglas J M Allen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR9610283A publication Critical patent/BR9610283A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
BR9610283A 1995-08-29 1996-07-05 Polimorfos da pró-droga 6-n-(l-ala-l-ala)-trovafloxacina BR9610283A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US510995P 1995-08-29 1995-08-29
PCT/IB1996/000653 WO1997008191A1 (en) 1995-08-29 1996-07-05 Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin

Publications (1)

Publication Number Publication Date
BR9610283A true BR9610283A (pt) 1999-03-16

Family

ID=21714229

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9610283A BR9610283A (pt) 1995-08-29 1996-07-05 Polimorfos da pró-droga 6-n-(l-ala-l-ala)-trovafloxacina

Country Status (35)

Country Link
US (1) US6080756A (pt)
EP (1) EP0847400B1 (pt)
JP (1) JPH11509188A (pt)
KR (1) KR100274736B1 (pt)
CN (1) CN1193977A (pt)
AP (1) AP639A (pt)
AR (1) AR004507A1 (pt)
AT (1) ATE208790T1 (pt)
AU (1) AU696414B2 (pt)
BR (1) BR9610283A (pt)
CA (1) CA2230303C (pt)
CO (1) CO4480740A1 (pt)
CZ (1) CZ291524B6 (pt)
DE (1) DE69617027T2 (pt)
DK (1) DK0847400T3 (pt)
DZ (1) DZ2088A1 (pt)
ES (1) ES2164892T3 (pt)
GT (1) GT199600061A (pt)
HR (1) HRP960396A2 (pt)
HU (1) HUP9900226A3 (pt)
IL (1) IL122652A (pt)
MA (1) MA23965A1 (pt)
NO (1) NO309039B1 (pt)
NZ (1) NZ310542A (pt)
OA (1) OA10670A (pt)
PL (1) PL185709B1 (pt)
PT (1) PT847400E (pt)
RU (1) RU2151152C1 (pt)
SK (1) SK283354B6 (pt)
TN (1) TNSN96110A1 (pt)
TR (1) TR199800340T1 (pt)
UA (1) UA48982C2 (pt)
WO (1) WO1997008191A1 (pt)
YU (1) YU48296A (pt)
ZA (1) ZA967281B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) * 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
CN105510497A (zh) * 2015-11-30 2016-04-20 精晶药业股份有限公司 L-丙氨酰-l-丙氨酸的定量检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
PL325203A1 (en) 1998-07-06
HRP960396A2 (en) 1998-04-30
CA2230303C (en) 2001-07-24
DE69617027D1 (de) 2001-12-20
AR004507A1 (es) 1998-12-16
PL185709B1 (pl) 2003-07-31
SK23798A3 (en) 1999-05-07
AP9600854A0 (en) 1996-10-31
JPH11509188A (ja) 1999-08-17
CZ291524B6 (cs) 2003-03-12
AU696414B2 (en) 1998-09-10
US6080756A (en) 2000-06-27
KR19990044231A (ko) 1999-06-25
ATE208790T1 (de) 2001-11-15
RU2151152C1 (ru) 2000-06-20
TR199800340T1 (xx) 1998-06-22
YU48296A (sh) 1998-12-23
DE69617027T2 (de) 2002-03-21
GT199600061A (es) 1998-01-31
NO980863D0 (no) 1998-02-27
HUP9900226A3 (en) 1999-11-29
KR100274736B1 (ko) 2000-12-15
AU6135196A (en) 1997-03-19
HUP9900226A2 (hu) 1999-05-28
AP639A (en) 1998-04-14
NO309039B1 (no) 2000-12-04
SK283354B6 (sk) 2003-06-03
NZ310542A (en) 1999-09-29
PT847400E (pt) 2002-03-28
MA23965A1 (fr) 1997-04-01
DK0847400T3 (da) 2002-03-25
CA2230303A1 (en) 1997-03-06
IL122652A0 (en) 1996-08-16
DZ2088A1 (fr) 2002-07-22
EP0847400A1 (en) 1998-06-17
CO4480740A1 (es) 1997-07-09
IL122652A (en) 2000-01-31
CN1193977A (zh) 1998-09-23
WO1997008191A1 (en) 1997-03-06
NO980863L (no) 1998-02-27
UA48982C2 (uk) 2002-09-16
ES2164892T3 (es) 2002-03-01
OA10670A (en) 2000-11-06
CZ55298A3 (cs) 1999-02-17
EP0847400B1 (en) 2001-11-14
ZA967281B (en) 1998-03-02
TNSN96110A1 (fr) 2005-03-15
MX9801665A (es) 1998-08-30

Similar Documents

Publication Publication Date Title
DE69522717D1 (de) Chinazolinderivate
DE69611361D1 (de) Chinazolin-derivate
NO974103D0 (no) Arylsulfonylaminohydroksamsyre-derivater
DE69610698T2 (de) Chinazolin-derivate
PT833828E (pt) Derivados de rapamicina
BR9611834A (pt) Derivados de oximetóxi-3-aril-pirona
NO964667D0 (no) Purin-6-on-derivater
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
KR970000222A (ko) 팩리택셀 유도체의 전구약물
DE69601527T2 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
PT856007E (pt) Derivados de ciclopeptidos
DE69628200T2 (de) Diarylalkenylamin-derivate
DE69627830D1 (de) Pyrazol-derivate
DE59607054D1 (de) 4-Amino-benzoylguanidin-Derivate
DE29505450U1 (de) Faltsignal
ATE177102T1 (de) Chromanderivate
DE59610106D1 (de) Fluorbenzylether-Derivate
DE69616554T2 (de) Sialinsäure-derivate
BR9610283A (pt) Polimorfos da pró-droga 6-n-(l-ala-l-ala)-trovafloxacina
ATE225347T1 (de) Aza-anthracyclinone-derivate
BR9603508A (pt) Derivados de alquenil-benzoilguanidina
ATE202088T1 (de) 4-mercapto-benzoylguanidin-derivate
DE69620514D1 (de) 5-aminoflavon-derivate
ATA45796A (de) Lysin-prolin-derivate

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements